JAGX · Forms 3, 4, 5
Insider trades at Jaguar Health, Inc.
No open-market insider buys or sells at Jaguar Health, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Jaguar Health, Inc. (JAGX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Jaguar Health, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John Micek | Director | Award | 7,377 | Form 4 | |||
| Steven R. King | Officer | Award | 11,740 | Form 4 | |||
| Lisa A Conte | Director | Award | 28,592 | Form 4 | |||
| Jonathan S. Wolin | Officer | Award | 11,740 | Form 4 | |||
| Pravin R Chaturvedi | Chief Scientific Officer | Award | 11,740 | Form 4 | |||
| James J Bochnowski | Director | Award | 6,363 | Form 4 | |||
| Jonathan B. Siegel | Director | Award | 7,377 | Form 4 | |||
| Anula Jayasuriya | Director | Award | 5,870 | Form 4 | |||
| Carol R. Lizak | Chief Financial Officer | Award | 11,740 | Form 4 | |||
| Lincoln Alternative Strategies LLC | 10% owner | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.